Apotex Leans Into Brand Ambitions With Formosa Deal
Acquires Canadian Rights To Novel Clobetasol Propionate Ophthalmic Treatment
Apotex has made another move to bolster its burgeoning branded business, striking a deal with Formosa Pharmaceuticals for Canadian rights to its novel clobetasol propionate ophthalmic suspension.
